Novel Rabbit Monoclonal Antibodies Technology Established at Spring!
As of April 2010 Spring Bioscience Corporation successfully developed a novel and robust process for making rabbit monoclonal antibodies.
Spring Bioscience has long recognized the benefits of rabbit monoclonal antibodies for their specificity and high affinity which makes them ideally suited to deliver optimal results in immunohistochemistry as well as other immunoassay. Through partnership with collaborators, Spring pioneered a series of rabbit monoclonal antibodies in the immunohistochemistry market. Spring’s SP clones have proven themselves time and time again as gold standards in the immunohistochemistry markers and this breakthrough will serve to further this leadership position.
After nearly a year of internal R&D, our scientists have generated an advanced rabbit monoclonal technology that will allow us to accelerate our delivery of a broader menu of these best-in-class antibodies to the market.